Biodexa Pharmaceuticals (BDRX) Common Equity (2013 - 2026)
Biodexa Pharmaceuticals' Common Equity was $12.9 million in the quarter ended Jun 30, 2026, down 15.5% from $15.26 million a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Common Equity (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Common Equity at Biodexa Pharmaceuticals came in at $15.04 million, up 41.4% from the prior year.
- Common Equity has now increased for three consecutive years, with a five-year compound annual growth rate of 11.8% (years ended Dec 2020 to Dec 2025).
- In earlier years, Common Equity was $10.64 million in the year ended Dec 31, 2024 (+82.8%), $5.82 million in the year ended Dec 31, 2023 (+48.7%), $3.91 million in the year ended Dec 31, 2022 (-72.8%) and $14.38 million in the year ended Dec 31, 2021 (+66.7%).
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Common Equity since the quarter ended Dec 31, 2024.
- Compared with a year earlier, Common Equity was higher in three of the last four quarters, with growth averaging 37.3%.
- The best year-over-year quarter for Common Equity over five years was the quarter ended Dec 31, 2024 (growth of 84.0%); the worst was the quarter ended Dec 31, 2022 (a decline of 73.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,129.91 Bn | 1,098.50 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 613.69 Bn | 532.22 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.05 Bn | 476.16 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 367.72 Bn | 322.10 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 297.87 Bn | 261.86 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.30 Bn | 234.99 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 235.86 Bn | 191.25 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 190.51 Bn | 164.71 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 169.83 Bn | 116.48 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Biodexa Pharmaceuticals | 4,025.62 | -23.40 Mn | - | 12.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.74 Mn |
| Dec 31, 2025 | 15.36 Mn |
| Jun 30, 2025 | 15.69 Mn |
| Dec 31, 2024 | 10.44 Mn |
| Jun 30, 2024 | 11.04 Mn |
| Dec 31, 2023 | 5.96 Mn |
| Jun 30, 2023 | 6.68 Mn |
| Dec 31, 2022 | 3.81 Mn |
| Jun 30, 2022 | 9.09 Mn |
| Dec 31, 2021 | 14.11 Mn |
| Dec 31, 2020 | 9.16 Mn |
| Jun 30, 2020 | 5.60 Mn |
| Dec 31, 2019 | 25.65 Mn |
| Jun 30, 2019 | 31.38 Mn |
| Dec 31, 2018 | 21.48 Mn |
| Jun 30, 2018 | 30.56 Mn |
| Dec 31, 2017 | 46.61 Mn |
| Jun 30, 2017 | 47.90 Mn |
| Dec 31, 2016 | 56.19 Mn |
| Jun 30, 2016 | 54.85 Mn |
API Access
Biodexa Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();